ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $191,000 | -25.7% | 5,781 | -20.8% | 0.01% | -12.5% |
| Q2 2022 | $257,000 | +15.2% | 7,302 | +50.6% | 0.01% | +60.0% |
| Q1 2022 | $223,000 | -39.6% | 4,848 | -12.9% | 0.01% | -37.5% |
| Q4 2021 | $369,000 | +7.0% | 5,566 | +0.7% | 0.01% | 0.0% |
| Q3 2021 | $345,000 | -27.8% | 5,530 | -4.2% | 0.01% | -11.1% |
| Q2 2021 | $478,000 | +32.0% | 5,770 | +5.7% | 0.01% | +28.6% |
| Q1 2021 | $362,000 | -14.0% | 5,460 | -0.5% | 0.01% | -22.2% |
| Q4 2020 | $421,000 | +78.4% | 5,490 | 0.0% | 0.01% | +80.0% |
| Q3 2020 | $236,000 | -0.4% | 5,490 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $237,000 | +48.1% | 5,490 | -1.4% | 0.01% | +50.0% |
| Q1 2020 | $160,000 | -55.4% | 5,568 | -1.5% | 0.00% | -50.0% |
| Q4 2019 | $359,000 | +120.2% | 5,653 | -2.4% | 0.01% | +100.0% |
| Q3 2019 | $163,000 | +5.2% | 5,793 | -0.9% | 0.00% | +33.3% |
| Q2 2019 | $155,000 | -71.4% | 5,843 | -92.1% | 0.00% | -72.7% |
| Q3 2016 | $542,000 | – | 73,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |